Log in to search using one of your social media accounts:

 

Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Conditions:   Autoimmune Diseases;   Pregnancy Related;   Systemic Lupus Erythematosus;   Cutaneous Lupus;   Rheumatoid Arthritis;   Sjogren's Syndrome;   Scleroderma Intervention:   Sponsor:   Duke University Not yet recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2017 Category: Research Source Type: clinical trials

Administration of Low-dose IL-2 in Established T1D
Conditions:   Diabetes Mellitus, Type 1;   Diabetes;   Diabetes, Autoimmune Interventions:   Drug: Proleukin® (Aldesleukin; IL-2);   Drug: Placebo - Concentrate Sponsors:   Jay S. Skyler;   National Institute of Allergy and Infectious Diseases (NIAID);   Diabetes Research Institute Foundation;   University of Florida;   University of California, San Francisco Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2017 Category: Research Source Type: clinical trials

Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD
Condition:   Warm Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD) Intervention:   Drug: APL-2 Sponsor:   Apellis Pharmaceuticals, Inc. Not yet recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2017 Category: Research Source Type: clinical trials

Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
DiscussionThis is the first randomised control trial to study the efficacy of rituximab as first-line treatment in CTD-associated ILD. The results generated should provide important information on the treatment of a life-threatening complication affecting a rare group of CTDs.Trial registrationClinicalTrials.gov, NCT01862926. Registered on 22 May 2013. (Source: Trials)
Source: Trials - June 15, 2017 Category: Research Source Type: clinical trials

Safety and Clinical Efficiency of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases
Conditions:   Fasting;   Chronic Disease;   Autoimmune Diseases;   Metabolic Disease;   High Blood Pressure;   Fatty Liver;   Kidney Stone;   Gall Stone;   Hysteromyoma Intervention:   Other: the 21-day fasting-like diet Sponsors:   Tsinghua University;   Nanshan Branch of Qilu Hospital Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2017 Category: Research Source Type: clinical trials

Safety and Clinical Efficiency of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases
Conditions:   Fasting;   Chronic Disease;   Autoimmune Diseases;   Metabolic Disease;   High Blood Pressure;   Fatty Liver;   Kidney Stone;   Gall Stone;   Hysteromyoma Intervention:   Other: the 21-day fasting-like diet Sponsors:   Tsinghua University;   Nanshan Branch of Qilu Hospital Recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2017 Category: Research Source Type: clinical trials